[1]
S. Schroecksnadel, J. Suljkanovic, C. Marth, A. González-Martín, and D. Lorusso, “Case 1 – Long-term response to bevacizumab and paclitaxel as second-line therapy in metastatic vaginal carcinoma:  ”, CBN, vol. 4, no. 1, pp. 36–40, Mar. 2016.